Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 3
2005 5
2006 8
2007 3
2008 6
2009 3
2010 6
2011 6
2012 9
2013 7
2014 8
2015 12
2016 13
2017 10
2018 10
2019 9
2020 14
2021 9
2022 9
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers.
El Kaoutari A, Fraunhoffer NA, Audebert S, Camoin L, Berthois Y, Gayet O, Roques J, Bigonnet M, Bongrain C, Ciccolini J, Iovanna JL, Dusetti NJ, Soubeyran P. El Kaoutari A, et al. Among authors: ciccolini j. EBioMedicine. 2023 Jun;92:104634. doi: 10.1016/j.ebiom.2023.104634. Epub 2023 May 29. EBioMedicine. 2023. PMID: 37257316 Free PMC article.
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency.
Etienne-Grimaldi MC, Pallet N, Boige V, Ciccolini J, Chouchana L, Barin-Le Guellec C, Zaanan A, Narjoz C, Taieb J, Thomas F, Loriot MA; Francophone Network of Pharmacogenetics (RNPGx) and the French Clinical Oncopharmacology Group (GPCO)-UNICANCER. Etienne-Grimaldi MC, et al. Among authors: ciccolini j. Eur J Cancer. 2023 Mar;181:3-17. doi: 10.1016/j.ejca.2022.11.028. Epub 2022 Dec 9. Eur J Cancer. 2023. PMID: 36621118 Review.
A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
Gravis G, Marino P, Olive D, Penault-LLorca F, Delord JP, Simon C, Lamrani-Ghaouti A, Sabatier R, Ciccolini J, Boher JM. Gravis G, et al. Among authors: ciccolini j. BMC Cancer. 2023 May 2;23(1):393. doi: 10.1186/s12885-023-10881-8. BMC Cancer. 2023. PMID: 37131154 Free PMC article.
Trastuzumab-induced cardiotoxicity: is it a personalized risk?
Milano GA, Serres E, Ferrero JM, Ciccolini J. Milano GA, et al. Among authors: ciccolini j. Curr Drug Targets. 2014;15(13):1200-4. doi: 10.2174/1389450115666141114151911. Curr Drug Targets. 2014. PMID: 25395105 Review.
153 results